Jellyfish to solve Alzheimer's

Amazing, after 15 years of watching jellyfish protein glow, Mark Underwood is finally seeing the flicker of real progress.
This month, Quincy Bioscience, the Wisconsin company co-founded by Underwood, received a U. S. patent for the jellyfish protein aequorin.
Last month, they released test results that showed the protein does improve memory.
This fall, they're trying for the gold standard: human clinical trials on people with the first stages of Alzheimer's and dementia to see if, finally there is something that works on a disease that destroys millions of aging minds.
Tests reported that people who "had a memory concern" saw better scores in 60 days of taking the jellyfish protein.
What a wonderful thing if this group finds a cure for Alzheimer's. "If we can push Alzheimer's back by five years, we can reduce it by 50 per cent. The challenge is keeping the brain alive."